1
MSM MSM 1 1 1 2 3 4 4 5 5 6 1 1 1 2003-ER-010 1 210042 2 650118 3 610017 4 100050 5 610041 6 650021 1
MSM 2
MSM 1. 2. 3
MSM 3. (%) (%) 2 P 34(17.3%) 163(82.7%) 24(13.6%) 152(86.4%) 0.93 8 74(37.6%) 123(62.4%) 40(22.7%) 136(77.3%) 9.64 63(32.0%) 134(68.0%) 21(11.9%) 155(88.1%) 21.41 84(42.6%) 113(57.4%) 48(27.3%) 128(72.7%) 9.60 4
MSM (%) (%) 2 P 48(24.4%) 149(75.6%) 25(14.2%) 151(85.8%) 6.10 30%50% 55(27.9%) 142(72.1%) 10(5.7%) 166(94.3%) 31.94 85(43.1%) 112(56.9%) 49(27.8%) 127(72.2%) 9.46 52(26.4%) 145(73.6%) 30(17.0%) 146(83.0%) 4.74 47(23.9%) 150(76.1%) 24(13.6%) 152(86.4%) 6.30 83(42.1%) 114(57.9%) 48(27.3%) 128(72.7%) 9.01 63(32.0%) 134(68.0%) 41(23.3%) 135(76.7%) 3.47 60(30.5%) 137(69.5%) 35(19.9%) 141(80.1%) 5.47 68(34.5%) 129(65.5%) 38(21.6%) 138(78.4%) 7.64 47(23.9%) 150(76.1%) 9(5.1%) 167(94.9%) 25.60 35(17.8%) 162(82.2%) 16(9.1%) 160(90.9%) 5.93 50(25.4%) 147(74.6%) 19(10.8%) 157(89.2%) 13.11 50(25.4%) 147(74.6%) 17(9.7%) 159(90.3%) 15.59 38(19.3%) 159(80.7%) 27(15.3%) 149(84.7%) 1.01 43(21.8%) 154(78.2%) 15(8.5%) 161(91.5%) 12.53 55(27.9%) 142(72.1%) 26(14.8%) 150(85.2%) 9.45 41(20.8%) 156(79.2%) 13(7.4%) 163(92.6%) 13.53 37(18.8%) 160(81.2%) 24(13.6%) 152(86.4%) 1.80 43(21.8%) 154(78.2%) 7(4.0%) 169(96.0%) 25.52 80(40.6%) 117(59.4%) 149(84.7%) 27(15.3%) 76.10 65(33.0%) 132(67.0%) 35(19.9%) 141(80.1%) 8.14 5
MSM 4. 5. % 6
MSM 7
MSM 8
MSM 9
10
11
12
13
STD/HIV STD/HIV 14
STD/HIV 15
STD/HIV 16
STD/HIV 17
18
19
20
21
22
2005 2005 23
2005 24
2005 25
26
27
28
VCT VCT 29
VCT 30
VCT 10 31
VCT 32
VCT 33
VCT 34
35
36
37
38
39
40
41
42
/ 43
HIV/AIDS/STDs 44
HIV/AIDS 45
AIDS/HIV 46
HIV 47
AIDS/STD HIV 48
HIV : 49
50
51
52